MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab
2018 ◽
Vol 179
(3)
◽
pp. 787-789
◽
2000 ◽
Vol 15
(4)
◽
pp. 764-770
◽